8-K: Aclarion, Inc. Adjourns Special Meeting of Stockholders to March 5, 2025
Press Release
Aclarion, Inc. has adjourned its Special Meeting of Stockholders to March 5, 2025, to solicit additional votes regarding proposals outlined in the definitive proxy statement.
Summary
- Aclarion, Inc. announced the adjournment of its Special Meeting of Stockholders on February 28, 2025.
- The meeting was adjourned to solicit additional votes for the proposals described in the company's definitive proxy statement filed with the SEC on February 3, 2025.
- The Special Meeting will reconvene on March 5, 2025, at 9:30 a.m. Mountain Time at the company's corporate office in Broomfield, Colorado.
- The record date for determining stockholders eligible to vote remains January 6, 2025.
- Stockholders as of the record date are encouraged to vote, and previously submitted proxies will be voted at the adjourned meeting unless revoked.
- Stockholders can change their vote until 11:59 p.m. Mountain Time on March 4, 2025.
Sentiment
Score: 5
Explanation: The announcement is neutral, simply stating the adjournment of a meeting to gather more votes. It doesn't convey strong positive or negative sentiment.
Positives
- The company is actively seeking stockholder input by adjourning the meeting to allow for additional votes.
Risks
- The adjournment of the meeting suggests potential difficulty in securing sufficient votes for the proposals.
- Forward-looking statements are subject to risks and uncertainties detailed in the company's SEC filings, including Forms 10-K and 10-Q.
Future Outlook
The company's future results are subject to risks and uncertainties, as detailed in their SEC filings.
Industry Context
Aclarion operates in the healthcare technology sector, focusing on treatments for low back and neck pain, a significant market.
Stakeholder Impact
- Shareholders are directly impacted by the proposals being voted on at the Special Meeting.
- The outcome of the vote could affect the company's strategic direction and future performance.
Next Steps
- Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
- The Special Meeting will reconvene on March 5, 2025.
Key Dates
| Date | Description |
|---|---|
| January 6, 2025 | Record date for determination of stockholders entitled to vote at the Special Meeting |
| February 3, 2025 | Filing date of the definitive proxy statement with the SEC |
| February 28, 2025 | Date of the Special Meeting adjournment |
| March 4, 2025 | Deadline for stockholders to change their vote (11:59 p.m. Mountain Time) |
| March 5, 2025 | Reconvened Special Meeting of Stockholders at 9:30 a.m. Mountain Time |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.